Interventional oncology for liver and lung metastases from colorectal cancer: The current state of the art

T. De Baere; L. Tselikas; E. Pearson; S. Yevitch; V. Boige; D. Malka; M. Ducreux; D. Goere; D. Elias; F. Nguyen; F. Deschamps

doi:10.1016/j.diii.2015.04.004

Interventional oncology for liver and lung metastases from colorectal cancer: The current state of the art

T. De Baere, L. Tselikas, E. Pearson, S. Yevitch, V. Boige, D. Malka, M. Ducreux, D. Goere, D. Elias, F. Nguyen, F. Deschamps

Institut Gustave Roussy

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Abstract

Interventional oncology is developing rapidly as a result of advances in imaging and medical devices. Although the treatments offered are recent and not yet fully validated in the guidelines, they allow non-invasive curative treatments to be offered to a growing number of patients. When it is used in a highly selected patients with less than three metastases under 2-3cm in size, percutaneous tumor ablation offers local efficacy similar to excision surgery with considerable sparing of the parenchyma, both for lung and liver metastases. Hepatic intra-arterial therapies (chemotherapy, radioembolization, and chemoembolization) are now g-salvageg methods after chemotherapy has failed and are being assessed in earlier lines of treatment.

Original language	English
Pages (from-to)	647-654
Number of pages	8
Journal	Diagnostic and interventional imaging
Volume	96
Issue number	6
DOIs	https://doi.org/10.1016/j.diii.2015.04.004
State	Published - Jun 2015
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2015 Éditions françaises de radiologie.

Keywords

Chemotherapy
Colorectal cancer
Image-guided surgery
Metastases
Radiofrequency

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.diii.2015.04.004

Cite this

@article{46e13c9f0e074fd69fc0b6e53129a505,

title = "Interventional oncology for liver and lung metastases from colorectal cancer: The current state of the art",

abstract = "Interventional oncology is developing rapidly as a result of advances in imaging and medical devices. Although the treatments offered are recent and not yet fully validated in the guidelines, they allow non-invasive curative treatments to be offered to a growing number of patients. When it is used in a highly selected patients with less than three metastases under 2-3cm in size, percutaneous tumor ablation offers local efficacy similar to excision surgery with considerable sparing of the parenchyma, both for lung and liver metastases. Hepatic intra-arterial therapies (chemotherapy, radioembolization, and chemoembolization) are now g-salvageg methods after chemotherapy has failed and are being assessed in earlier lines of treatment.",

keywords = "Chemotherapy, Colorectal cancer, Image-guided surgery, Metastases, Radiofrequency",

author = "{De Baere}, T. and L. Tselikas and E. Pearson and S. Yevitch and V. Boige and D. Malka and M. Ducreux and D. Goere and D. Elias and F. Nguyen and F. Deschamps",

note = "Publisher Copyright: {\textcopyright} 2015 {\'E}ditions fran{\c c}aises de radiologie.",

year = "2015",

month = jun,

doi = "10.1016/j.diii.2015.04.004",

language = "אנגלית",

volume = "96",

pages = "647--654",

journal = "Diagnostic and interventional imaging",

issn = "2211-5684",

publisher = "Elsevier Masson",

number = "6",

}

TY - JOUR

T1 - Interventional oncology for liver and lung metastases from colorectal cancer

T2 - The current state of the art

AU - De Baere, T.

AU - Tselikas, L.

AU - Pearson, E.

AU - Yevitch, S.

AU - Boige, V.

AU - Malka, D.

AU - Ducreux, M.

AU - Goere, D.

AU - Elias, D.

AU - Nguyen, F.

AU - Deschamps, F.

PY - 2015/6

Y1 - 2015/6

N2 - Interventional oncology is developing rapidly as a result of advances in imaging and medical devices. Although the treatments offered are recent and not yet fully validated in the guidelines, they allow non-invasive curative treatments to be offered to a growing number of patients. When it is used in a highly selected patients with less than three metastases under 2-3cm in size, percutaneous tumor ablation offers local efficacy similar to excision surgery with considerable sparing of the parenchyma, both for lung and liver metastases. Hepatic intra-arterial therapies (chemotherapy, radioembolization, and chemoembolization) are now g-salvageg methods after chemotherapy has failed and are being assessed in earlier lines of treatment.

AB - Interventional oncology is developing rapidly as a result of advances in imaging and medical devices. Although the treatments offered are recent and not yet fully validated in the guidelines, they allow non-invasive curative treatments to be offered to a growing number of patients. When it is used in a highly selected patients with less than three metastases under 2-3cm in size, percutaneous tumor ablation offers local efficacy similar to excision surgery with considerable sparing of the parenchyma, both for lung and liver metastases. Hepatic intra-arterial therapies (chemotherapy, radioembolization, and chemoembolization) are now g-salvageg methods after chemotherapy has failed and are being assessed in earlier lines of treatment.

KW - Chemotherapy

KW - Colorectal cancer

KW - Image-guided surgery

KW - Metastases

KW - Radiofrequency

UR - http://www.scopus.com/inward/record.url?scp=84945963428&partnerID=8YFLogxK

U2 - 10.1016/j.diii.2015.04.004

DO - 10.1016/j.diii.2015.04.004

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 25985998

AN - SCOPUS:84945963428

SN - 2211-5684

VL - 96

SP - 647

EP - 654

JO - Diagnostic and interventional imaging

JF - Diagnostic and interventional imaging

IS - 6

ER -

Interventional oncology for liver and lung metastases from colorectal cancer: The current state of the art

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this